Crystallex International, Sprint Nextel: Early Volume Plays

NEW YORK (TheStreet) -- Crystallex International (KRY) was one of several stocks trading near $5 poised to move on above-average volume Monday after the Canadian gold producer announced a partnership deal.

Crystallex International said it has signed an agreement with China Railway Resources Group to create a strategic partnership for the development of the Las Cristinas gold project in Bolivar State, Venezuela.

Crystallex shares surged by 29 cents, or 53.7%, to 83 cents in the premarket session. The three-month average daily volume for Crystallex is 911,000, according to Yahoo! Finance.

Elsewhere, Sprint Nextel (S) rose 18 cents, or 3.8%, to $4.96 in the premarket session after the wireless company said Friday sales of the HTC EVO 4G marked the "largest quantity of a single phone sold in one day ever" for Sprint. Sales led to temporary shortages of the device at some of the 22,000 sales locations in the U.S., Sprint said. The three-month average daily volume for Sprint is 69.89 million.

Stocks Under $5 Top 10 Buy-Rated Stocks Under $5

ArQule (ARQL) shares gained 14 cents, or 2.5%, to $5.75 in the premarket session after the company and Japan's Daiichi Sankyo presented Phase II clinical trial data that showed "encouraging overall survival results" with ARQ 197 combined with erlotinib in patients with advanced refractory non-small-cell lung cancer (NSLC). The 50-day average daily volume for ArQule is 1.65 million, according to the Nasdaq.

Meanwhile, BioSante Pharmaceuticals (BPAX) jumped by 16 cents, or 8.3%, to $2.10 in the premarket session after the company said its GVAX CML vaccine received orphan-drug status from the Food and Drug Administration as a treatment for chronic myeloid leukemia. The 50-day average daily volume for BioSante is 89,000.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

>To order reprints of this article, click here: Reprints